Cohen HJ, Pieper CF, Harris T et al. The association of plasma IL-6 levels
with functional disability in community dwelling elderly. J Gerontol A Biol
Sci Med Sci 1997;52A:M201–M208. 45.
15. Harris TB, Ferrucci L, Tracy RP et al. Associations of elevated interleukin- 6 and C-reactive protein levels with mortality in the elderly. Am J Med
1999;106:506–512. 46.
16. Ferrucci L, Harris TB, Guralnik JM et al. Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc 1999;47:639–646.
17. Mooradian AD, Reed RL, Osterweil D et al. Detectable serum levels of tu- 47.
mor necrosis factor alpha may predict early mortality in elderly institutionalized patients. J Am Geriatr Soc 1991;39:891–894. 48.
18. Thomas VS, Rockwood K, McDowell I. Multidimensionality in instrumental and basic activities of daily living. J Clin Epidemiol 1998;51:315–321.
19. Weaver J, Seeman T. Interleukin-6 as a predictor of cognitive function and 49.
cognitive decline. J Am Geriatr Soc 2000;48(Suppl. 1):S2.
20. Woodroofe C, Mueller W, Ruether U. Long term consequences of interleu- 50.
kin-6 overexpression in transgenic mice. DNA Cell Biol 1992;11:587–592.
21. Böttinger EP, Letterio JJ, Roberts AB. Biology of TGF- in knockout and
transgenic mouse models. Kidney Int 1997;51:1355–1360. 51.
22. Licinio J, Kling MA, Hauser P. Cytokines and brain function: Relevance to
interferon- -induced mood and cognitive changes. Semin Oncol 1998; 52.
25(Suppl. 1):30–38.
23. Anisman H, Merali Z. Anhedonic and anxiogenic effects of cytokine exposure. Adv Exp Med Biol 1999;461:199–233. 53.
24. Dunn AJ, Swiergiel AH. The role of cytokines in infection-related behavior.
Ann N Y Acad Sci 1998;840:577–585.
25. Connor TJ, Leonard BE. Depression, stress and immunological activation:
The role of cytokines in depressive disorders. Life Sci 1998;62:583–606. 54.
26. Dantzer R, Bluthé RM, Layé S et al. Cytokines and sickness behavior. Ann
N Y Acad Sci 1998;840:586–590.
27. Dunn AJ. Endotoxin-induced activation of cerebral catecholamine and se- 55.
rotonin metabolism: Comparison with interleukin-1. J Pharmacol Exp
Ther 1992;261:964–969.
28. Gutierrez EG, Banks WA, Kastin AJ. Murine tumor necrosis factor alpha is 56.
transported from blood to brain in the mouse. J Neuroimmunol 1993;47:
169–176. 57.
29. Gutierrez EG, Banks WA, Kastin AJ. Blood-borne interleukin-1 receptor
antagonist crosses the blood brain barrier. J Neuroimmunol 1994;55:
153–160. 58.
30. Maier SF, Goehler LE, Fleshner M et al. The role of the vagus nerve in cy- tokine-to-brain communication. Ann N Y Acad Sci 1998;840:289–300.
31. Wong ML, Bongiorno PB, Al-Shekhlee A et al. IL-1 beta, IL-1 receptor
type 1 and iNOS gene expression in rat brain vasculature and perivascular 59.
areas. Neuroreport 1996;7:2445–2448.
32. Anthony DC, Bolton SJ, Fearn S et al. Age-related effects of interleukin-1 60.
beta on polymorphonuclear neutrophil-dependent increases in blood–brain
barrier permeability in rats. Brain 1997;120:435–444.
33. Hickey WF. P selectin, pioneer cells and the path to inflammation. Brain 61.
2000;123:1073–1074.
34. Ek M, Kurosawa M, Lundeberg T et al. Activation of vagal afferents after
intravenous injection of interleukin-1 : Role of endogenous prostaglan- 62.
dins. J Neurosci 1998;18:9471–9479.
35. Goehler LE, Gaykema RP, Nguyen KT et al. Interleukin-1 in immune
cells of the abdominal vagus nerve: A link between the immune and ner- 63.
vous sytems? J Neurosci 1999;19:2799–2806.
36. Sehic E, Blatteis CM. Blockade of lipopolysaccharide-induced fever by sub- 64.
diaphragmatic vagotomy in guinea pigs. Brain Res 1996;726:160–166.
37. Bret-Dibat JL, Bluthé RM, Kent S et al. Lipopolysaccharide and interleukin-1 depress food-motivated behavior in mice by a vagal-mediated mecha- 65.
nism. Brain Behav Immun 1995;9:242–246.
38. Layé S, Bluthé RM, Kent S et al. Subdiaphragmatic vagotomy blocks in- duction of IL-1 mRNA in mice brain in response to peripheral LPS. Am J 66.
Physiol 1995;268:R1327–R1331.
39. Hansen MK, Taishi P, Chen Z et al. Vagotomy blocks the induction of in- 67.
terleukin-1 (IL-1 ) mRNA in the brain of rats in response to systemic
IL-1 . J Neurosci 1998;18:2247–2253. 68.
40. Benveniste EN. Cytokine actions in the central nervous system. Cytokine
Growth Factor Rev 1998;9:259–275. 69.
41. Vitkovic L, Boackaert J, Jacque C. Inflammatory cytokines: Neuromodulators in normal brain? J Neurochem 2000;74:457–471. 70.
42. Mohankumar PS, Thyagarajan S, Quadri SK. Interleukin-1 stimulates the 71.
release of dopamine and dihydroxyphenylacetic acid from the hypothalamus in vivo. Life Sci 1991;48:925–930. 72.
43. Shintani F, Kanba S, Nakaki T et al. Interleukin-1 beta augments release of
norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus. 73.
J Neurosci 1993;13:3574–3581.
44. Linthorst AC, Flachskamm C, Muller-Preuss P et al. Effect of bacterial en- 74.
dotoxin and interleukin-1 beta on hippocampal serotonergic neurotrans-
